Skip to main content
SpringerLink
Log in

Radiation Therapy for Chondrosarcoma

  • Chapter
  • First Online:
Chondrosarcoma

  • 521 Accesses

Abstract

Although surgical resection is the mainstay of treatment for primary chondrosarcoma, complete resection with negative margins is often difficult to achieve, especially in the skull base and in the spine. Radiation therapy is an essential component of the local disease control armamentarium. Radiation has a role in the adjuvant setting after incomplete resection, as a definitive modality when resection is not feasible, as a tool for salvage after recurrence, and in the setting of metastatic disease. However, radiation therapy delivery in these locations is also challenging because effective treatment requires high cumulative doses (~70 Gy or higher), and the treatment target is often adjacent to critical structures (e.g., brainstem, spinal cord, cranial nerves). Advanced radiation treatment modalities are critical to achieve the appropriate dose and to spare critical structures. Patients should be considered for particle-based therapies (proton or carbon ion) when possible. Photon-based therapies should be delivered using advanced image guidance and intensity-modulated radiotherapy. For smaller tumors in the skull base, stereotactic radiosurgery should be considered. Radiation therapy is often administered postoperatively, though combined preoperative and postoperative strategies have been effective in the spine and the pelvis. A multidisciplinary approach in an experienced center is recommended for optimal treatment of this rare malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Catanzano AA, et al. Revisiting the role of radiation therapy in chondrosarcoma: a National Cancer Database Study. Sarcoma. 2019;2019:4878512.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Goda JS, et al. High-risk extracranial chondrosarcoma: long-term results of surgery and radiation therapy. Cancer. 2011;117(11):2513–9.

    Article  PubMed  Google Scholar 

  3. Network, N.C.C. NCCN clinical practice guidelines in oncology: bone cancer. Version 1.2020. August 12, 2019 ed. 2019: NCCN.

    Google Scholar 

  4. Palm RF, et al. The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: an analysis of the National Cancer Data Base. Cancer. 2019;125(4):642–51.

    Article  CAS  PubMed  Google Scholar 

  5. Holtzman AL, et al. Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study. J Neuro-Oncol. 2019;142(3):557–63.

    Article  CAS  Google Scholar 

  6. Kano H, Iyer A, Lunsford LD. Skull base chondrosarcoma radiosurgery: a literature review. Neurosurgery. 2014;61 Suppl 1:155–8.

    Article  PubMed  Google Scholar 

  7. Kano H, et al. Skull base chondrosarcoma radiosurgery: report of the North American Gamma Knife Consortium. J Neurosurg. 2015;123(5):1268–75.

    Article  PubMed  Google Scholar 

  8. DeLaney TF, et al. Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys. 2009;74(3):732–9.

    Article  CAS  PubMed  Google Scholar 

  9. Butala AA, Lo SS, Jones JA. Advanced radiotherapy for metastatic disease-a major stride or a futile effort? Ann Palliat Med. 2019;8(3):337–51.

    Article  PubMed  Google Scholar 

  10. Song K, et al. Does resection of the primary tumor improve survival in patients with metastatic chondrosarcoma? Clin Orthop Relat Res. 2019;477(3):573–83.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Treasure T, et al. Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness? Thorax. 2014;69(10):946–9.

    Article  PubMed  Google Scholar 

  12. Marulli G, et al. Survival and prognostic factors following pulmonary metastasectomy for sarcoma. J Thorac Dis. 2017;9(Suppl 12):S1305–15.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kim S, et al. Pulmonary resection of metastatic sarcoma: prognostic factors associated with improved outcomes. Ann Thorac Surg. 2011;92(5):1780–6; discussion 1786–7.

    Article  PubMed  Google Scholar 

  14. Digesu CS, et al. Management of sarcoma metastases to the lung. Surg Oncol Clin N Am. 2016;25(4):721–33.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Palma DA, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019;393(10185):2051–8.

    Article  PubMed  Google Scholar 

  16. Soyfer V, et al. Single-institution experience of SBRT for lung metastases in sarcoma patients. Am J Clin Oncol. 2017;40(1):83–5.

    Article  PubMed  Google Scholar 

  17. Navarria P, et al. Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. Eur J Cancer. 2015;51(5):668–74.

    Article  PubMed  Google Scholar 

  18. Frakulli R, et al. Stereotactic radiotherapy in the treatment of lung metastases from bone and soft-tissue sarcomas. Anticancer Res. 2015;35(10):5581–6.

    CAS  PubMed  Google Scholar 

  19. Mehta N, et al. Safety and efficacy of stereotactic body radiation therapy in the treatment of pulmonary metastases from high grade sarcoma. Sarcoma. 2013;2013:360214.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Lindsay AD, et al. Treatment of sarcoma lung metastases with stereotactic body radiotherapy. Sarcoma. 2018;2018:9132359.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Baumann BC, et al. Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: a potential alternative to resection. J Surg Oncol. 2016;114(1):65–9.

    Article  PubMed  Google Scholar 

  22. Fiorenza F, et al. Risk factors for survival and local control in chondrosarcoma of bone. J Bone Joint Surg Br. 2002;84(1):93–9.

    Article  CAS  PubMed  Google Scholar 

  23. Leddy LR, Holmes RE. Chondrosarcoma of bone. Cancer Treat Res. 2014;162:117–30.

    Article  PubMed  Google Scholar 

  24. Bergh P, et al. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases. Cancer. 2001;91(7):1201–12.

    Article  CAS  PubMed  Google Scholar 

  25. Giuffrida AY, et al. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am. 2009;91(5):1063–72.

    Article  PubMed  Google Scholar 

  26. Bindiganavile S, et al. Long-term outcome of chondrosarcoma: a single institutional experience. Cancer Res Treat. 2015;47(4):897–903.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Donati D, et al. Surgical treatment and outcome of conventional pelvic chondrosarcoma. J Bone Joint Surg Br. 2005;87(11):1527–30.

    Article  CAS  PubMed  Google Scholar 

  28. Van Gompel JJ, Janus JR. Chordoma and chondrosarcoma. Otolaryngol Clin N Am. 2015;48(3):501–14.

    Article  Google Scholar 

  29. De Amorim Bernstein K, DeLaney T. Chordomas and chondrosarcomas-The role of radiation therapy. J Surg Oncol. 2016;114(5):564–9.

    Article  PubMed  Google Scholar 

  30. Bloch O, Parsa AT. Skull base chondrosarcoma: evidence-based treatment paradigms. Neurosurg Clin N Am. 2013;24(1):89–96.

    Article  PubMed  Google Scholar 

  31. Bloch OG, et al. Cranial chondrosarcoma and recurrence. Skull Base. 2010;20(3):149–56.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Iyer A, et al. Stereotactic radiosurgery for intracranial chondrosarcoma. J Neuro-Oncol. 2012;108(3):535–42.

    Article  Google Scholar 

  33. Gelderblom H, et al. The clinical approach towards chondrosarcoma. Oncologist. 2008;13(3):320–9.

    Article  PubMed  Google Scholar 

  34. Kitamura Y, Sasaki H, Yoshida K. Genetic aberrations and molecular biology of skull base chordoma and chondrosarcoma. Brain Tumor Pathol. 2017;34(2):78–90.

    Article  PubMed  Google Scholar 

  35. Boehme KA, et al. Chondrosarcoma: a rare misfortune in aging human cartilage? The role of stem and progenitor cells in proliferation, malignant degeneration and therapeutic resistance. Int J Mol Sci. 2018;19(1):311.

    Article  PubMed Central  CAS  Google Scholar 

  36. Javad Parvizi GKK. Chapter 49 - Chondrosarcoma. In: High yield orthopaedics. Philadelphia, PA: Saunders/Elsevier; 2010. https://www.worldcat.org/title/high-yield-orthopaedics/oclc/698080054.

  37. Raza SM, et al. Multimodality treatment of skull base chondrosarcomas: the role of histology specific treatment protocols. Neurosurgery. 2017;81(3):520–30.

    Article  PubMed  Google Scholar 

  38. Onishi AC, Hincker AM, Lee FY. Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets. Sarcoma. 2011;2011:381564.

    Article  PubMed  Google Scholar 

  39. de Jong Y, et al. Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genes. Clin Sarcoma Res. 2019;9:9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Girard N, et al. Heterogeneity of chondrosarcomas response to irradiations with X-rays and carbon ions: a comparative study on five cell lines. J Bone Oncol. 2020;22:100283.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Richardson MS. Pathology of skull base tumors. Otolaryngol Clin N Am. 2001;34(6):1025–42, vii.

    Article  CAS  Google Scholar 

  42. Samii A, et al. Surgical treatment of skull base chondrosarcomas. Neurosurg Rev. 2009;32(1):67–75; discussion 75.

    Article  PubMed  Google Scholar 

  43. Lustig LR, Sciubba J, Holliday MJ. Chondrosarcomas of the skull base and temporal bone. J Laryngol Otol. 2007;121(8):725–35.

    Article  CAS  PubMed  Google Scholar 

  44. Amichetti M, et al. A systematic review of proton therapy in the treatment of chondrosarcoma of the skull base. Neurosurg Rev. 2010;33(2):155–65.

    Article  PubMed  Google Scholar 

  45. Wanebo JE, et al. Management of cranial base chondrosarcomas. Neurosurgery. 2006;58(2):249–55; discussion 249–55.

    Article  PubMed  Google Scholar 

  46. Sekhar LN, et al. Chordomas and chondrosarcomas of the skull base: results and complications of surgical management. Neurosurg Focus. 2001;10(3):E2.

    Article  CAS  PubMed  Google Scholar 

  47. Bohman LE, et al. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis. World Neurosurg. 2014;82(5):806–14.

    Article  PubMed  Google Scholar 

  48. Jones PS, et al. Outcomes and patterns of care in adult skull base chondrosarcomas from the SEER database. J Clin Neurosci. 2014;21(9):1497–502.

    Article  PubMed  Google Scholar 

  49. Holliday EB, et al. Postoperative proton therapy for chordomas and chondrosarcomas of the spine: adjuvant versus salvage radiation therapy. Spine (Phila Pa 1976). 2015;40(8):544–9.

    Article  Google Scholar 

  50. Oghalai JS, et al. Skull base chondrosarcoma originating from the petroclival junction. Otol Neurotol. 2005;26(5):1052–60.

    Article  PubMed  Google Scholar 

  51. Li D, et al. Proposed treatment paradigm for intracranial chondrosarcomas based on multidisciplinary coordination. World Neurosurg. 2018;109:e517–30.

    Article  PubMed  Google Scholar 

  52. Carlson ML, et al. Petroclival chondrosarcoma: a multicenter review of 55 cases and new staging system. Otol Neurotol. 2016;37(7):940–50.

    Article  PubMed  Google Scholar 

  53. Mattke M, et al. High control rates of proton- and carbon-ion-beam treatment with intensity-modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center. Cancer. 2018;124(9):2036–44.

    Article  CAS  PubMed  Google Scholar 

  54. Uhl M, et al. High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term results. Cancer. 2014;120(10):1579–85.

    Article  PubMed  Google Scholar 

  55. McNaney D, et al. Fifteen year radiotherapy experience with chondrosarcoma of bone. Int J Radiat Oncol Biol Phys. 1982;8(2):187–90.

    Article  CAS  PubMed  Google Scholar 

  56. Krochak R, et al. Results of radical radiation for chondrosarcoma of bone. Radiother Oncol. 1983;1(2):109–15.

    Article  CAS  PubMed  Google Scholar 

  57. Sahgal A, et al. Image-guided, intensity-modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: preliminary outcomes. Neuro-Oncology. 2015;17(6):889–94.

    Article  CAS  PubMed  Google Scholar 

  58. Debus J, et al. Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys. 2000;47(3):591–6.

    Article  CAS  PubMed  Google Scholar 

  59. Hauptman JS, et al. Challenges in linear accelerator radiotherapy for chordomas and chondrosarcomas of the skull base: focus on complications. Int J Radiat Oncol Biol Phys. 2012;83(2):542–51.

    Article  PubMed  Google Scholar 

  60. Gwak HS, et al. Hypofractionated stereotactic radiation therapy for skull base and upper cervical chordoma and chondrosarcoma: preliminary results. Stereotact Funct Neurosurg. 2005;83(5–6):233–43.

    Article  PubMed  Google Scholar 

  61. Martin JJ, et al. Radiosurgery for chordomas and chondrosarcomas of the skull base. J Neurosurg. 2007;107(4):758–64.

    Article  PubMed  Google Scholar 

  62. Jiang B, et al. CyberKnife radiosurgery for the management of skull base and spinal chondrosarcomas. J Neuro-Oncol. 2013;114(2):209–18.

    Article  Google Scholar 

  63. Koga T, Shin M, Saito N. Treatment with high marginal dose is mandatory to achieve long-term control of skull base chordomas and chondrosarcomas by means of stereotactic radiosurgery. J Neuro-Oncol. 2010;98(2):233–8.

    Article  Google Scholar 

  64. Förander P, et al. Combination of microsurgery and Gamma Knife surgery for the treatment of intracranial chondrosarcomas. J Neurosurg. 2006;105 Suppl:18–25.

    Article  PubMed  Google Scholar 

  65. Krishnan S, et al. Radiosurgery for cranial base chordomas and chondrosarcomas. Neurosurgery. 2005;56(4):777–84; discussion 777–84.

    Article  PubMed  Google Scholar 

  66. Hasegawa T, et al. Gamma Knife surgery for skull base chordomas and chondrosarcomas. J Neurosurg. 2007;107(4):752–7.

    Article  PubMed  Google Scholar 

  67. Vasudevan HN, et al. Management of chordoma and chondrosarcoma with fractionated stereotactic radiotherapy. Front Surg. 2017;4:35.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Simon F, et al. Surgery and protontherapy in Grade I and II skull base chondrosarcoma: a comparative retrospective study. PLoS One. 2018;13(12):e0208786.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Rosenberg AE, et al. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol. 1999;23(11):1370–8.

    Article  CAS  PubMed  Google Scholar 

  70. Ares C, et al. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. Int J Radiat Oncol Biol Phys. 2009;75(4):1111–8.

    Article  PubMed  Google Scholar 

  71. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol. 1999;175 Suppl 2:57–63.

    Article  CAS  PubMed  Google Scholar 

  72. Austin-Seymour M, et al. Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg. 1989;70(1):13–7.

    Article  CAS  PubMed  Google Scholar 

  73. Debus J, et al. Brainstem tolerance to conformal radiotherapy of skull base tumors. Int J Radiat Oncol Biol Phys. 1997;39(5):967–75.

    Article  CAS  PubMed  Google Scholar 

  74. Feuvret L, et al. Efficacy and safety of adjuvant proton therapy combined with surgery for chondrosarcoma of the skull base: a retrospective, population-based study. Int J Radiat Oncol Biol Phys. 2016;95(1):312–21.

    Article  PubMed  Google Scholar 

  75. Weber DC, et al. Long term outcome of skull-base chondrosarcoma patients treated with high-dose proton therapy with or without conventional radiation therapy. Radiother Oncol. 2018;129(3):520–6.

    Article  PubMed  Google Scholar 

  76. Hug EB, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg. 1999;91(3):432–9.

    Article  CAS  PubMed  Google Scholar 

  77. Noël G, et al. Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure. Strahlenther Onkol. 2003;179(4):241–8.

    Article  PubMed  Google Scholar 

  78. Feuvret L, et al. A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors. Int J Radiat Oncol Biol Phys. 2007;69(3):944–54.

    Article  PubMed  Google Scholar 

  79. Lu VM, et al. Carbon ion radiotherapy for skull base chordomas and chondrosarcomas: a systematic review and meta-analysis of local control, survival, and toxicity outcomes. J Neuro-Oncol. 2020;147(3):503–13.

    Article  CAS  Google Scholar 

  80. Schulz-Ertner D, et al. Carbon ion radiotherapy of skull base chondrosarcomas. Int J Radiat Oncol Biol Phys. 2007;67(1):171–7.

    Article  PubMed  Google Scholar 

  81. Combs SE, et al. Carbon ion radiotherapy performed as re-irradiation using active beam delivery in patients with tumors of the brain, skull base and sacral region. Radiother Oncol. 2011;98(1):63–7.

    Article  PubMed  Google Scholar 

  82. Guan X, et al. The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine. Radiat Oncol. 2019;14(1):206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Hasegawa A, et al. Outcomes of visual acuity in carbon ion radiotherapy: analysis of dose-volume histograms and prognostic factors. Int J Radiat Oncol Biol Phys. 2006;64(2):396–401.

    Article  CAS  PubMed  Google Scholar 

  84. Koto M, et al. Risk factors for brain injury after carbon ion radiotherapy for skull base tumors. Radiother Oncol. 2014;111(1):25–9.

    Article  PubMed  Google Scholar 

  85. Peeters A, et al. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons. Radiother Oncol. 2010;95(1):45–53.

    Article  PubMed  Google Scholar 

  86. Nikoghosyan AV, et al. Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study. BMC Cancer. 2010;10:606.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Hug EB, Slater JD. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. Neurosurg Clin N Am. 2000;11(4):627–38.

    Article  CAS  PubMed  Google Scholar 

  88. Schoenfeld AJ, et al. Chondrosarcoma of the mobile spine: a review of 21 cases treated at a single center. Spine (Phila Pa 1976). 2012;37(2):119–26.

    Article  Google Scholar 

  89. McLoughlin GS, Sciubba DM, Wolinsky JP. Chondroma/chondrosarcoma of the spine. Neurosurg Clin N Am. 2008;19(1):57–63.

    Article  PubMed  Google Scholar 

  90. Murray FR, et al. Prognostic factors for spinal chordomas and chondrosarcomas treated with postoperative pencil-beam scanning proton therapy: a large, single-institution experience. J Neurosurg Spine. 2020:1–10.

    Google Scholar 

  91. Dickman CA, Fehlings M, Gokaslan ZL. Spinal cord and spinal column tumors: principles and practice. Stuttgart, Germany: Georg Thieme Verlag; 2006. https://www.worldcat.org/title/spinal-cord-and-spinal-column-tumors-principles-and-practice/oclc/1170993163&referer=brief_results.

  92. Boriani S, et al. Chondrosarcoma of the mobile spine: report on 22 cases. Spine (Phila Pa 1976). 2000;25(7):804–12.

    Article  CAS  Google Scholar 

  93. York JE, et al. Chondrosarcoma of the spine: 1954 to 1997. J Neurosurg. 1999;90(1 Suppl):73–8.

    CAS  PubMed  Google Scholar 

  94. Bhatt AD, et al. High-dose proton beam-based radiation therapy in the management of extracranial chondrosarcomas. Int J Part Ther. 2017;3(3):373–81.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Tatsuzaki H, Urie MM. Importance of precise positioning for proton beam therapy in the base of skull and cervical spine. Int J Radiat Oncol Biol Phys. 1991;21(3):757–65.

    Article  CAS  PubMed  Google Scholar 

  96. Yadav P, Paliwal BR, Kozak K. Dosimetric comparison of photon and proton treatment techniques for chondrosarcoma of thoracic spine. Med Dosim. 2013;38(3):233–7.

    Article  PubMed  Google Scholar 

  97. Indelicato DJ, et al. A prospective outcomes study of proton therapy for chordomas and chondrosarcomas of the spine. Int J Radiat Oncol Biol Phys. 2016;95(1):297–303.

    Article  PubMed  Google Scholar 

  98. Imai R, Kamada T, Araki N. Clinical efficacy of carbon ion radiotherapy for unresectable chondrosarcomas. Anticancer Res. 2017;37(12):6959–64.

    CAS  PubMed  Google Scholar 

  99. Austin JP, et al. Probable causes of recurrence in patients with chordoma and chondrosarcoma of the base of skull and cervical spine. Int J Radiat Oncol Biol Phys. 1993;25(3):439–44.

    Article  CAS  PubMed  Google Scholar 

  100. Bus MPA, et al. Conventional primary central chondrosarcoma of the pelvis: prognostic factors and outcome of surgical treatment in 162 patients. J Bone Joint Surg Am. 2018;100(4):316–25.

    Article  PubMed  Google Scholar 

  101. Tsuda Y, et al. Is the width of a surgical margin associated with the outcome of disease in patients with peripheral chondrosarcoma of the pelvis? A multicenter study. Clin Orthop Relat Res. 2019;477(11):2432–40.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Weber KL, Pring ME, Sim FH. Treatment and outcome of recurrent pelvic chondrosarcoma. Clin Orthop Relat Res. 2002;397:19–28.

    Article  Google Scholar 

  103. Chen L, et al. Prognostic nomograms to predict overall survival and cancer-specific survival in patients with pelvic chondrosarcoma. Cancer Med. 2019;8(12):5438–49.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Wagner TD, et al. Combination short-course preoperative irradiation, surgical resection, and reduced-field high-dose postoperative irradiation in the treatment of tumors involving the bone. Int J Radiat Oncol Biol Phys. 2009;73(1):259–66.

    Article  PubMed  Google Scholar 

  105. Feigl GC, et al. Evaluation of a new concept for the management of skull base chordomas and chondrosarcomas. J Neurosurg. 2005;102 Suppl:165–70.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA

    Ting Martin Ma & Anusha Kalbasi

  2. Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Thomas DeLaney

Authors
  1. Ting Martin Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas DeLaney
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anusha Kalbasi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anusha Kalbasi .

Editor information

Editors and Affiliations

  1. Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

    Francis J. Hornicek

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ma, T.M., DeLaney, T., Kalbasi, A. (2021). Radiation Therapy for Chondrosarcoma. In: Hornicek, F.J. (eds) Chondrosarcoma. Springer, Cham. https://doi.org/10.1007/978-3-030-74572-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-74572-1_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-74571-4

  • Online ISBN: 978-3-030-74572-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation